SEC 13F Intelligence

Orbimed Advisors LLC / PRAX

Orbimed Advisors LLC’s Praxis Precision Medicines I Position

Does Orbimed Advisors LLC own Praxis Precision Medicines I (PRAX)? Yes — 172.5K shares worth $56M (+1.10% of its 13F portfolio) as of Q1 2026, up from 94.5K shares the prior filed quarter.

Position Value
$56M
Q1 2026
Shares
172.5K
% of Portfolio
+1.10%
Quarters Held
3
currently held

Position History PRAX

Reported value by quarter
Q1 ’24: $28MQ1 ’24Q4 ’25: $28MQ4 ’25Q1 ’26: $56MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026172.5K$56M+1.10%
Q4 202594.5K$28M+0.57%
Q1 2024460.5K$28M+0.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of PRAX.